Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,466,334 papers from all fields of science
Search
Sign In
Create Free Account
celecoxib
Known as:
4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
, Celecoxib [Chemical/Ingredient]
, Célécoxib
Expand
A nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. Celecoxib selectively inhibits cyclo-oxygenase-2 activity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
35 relations
Adenomatous Polyposis Coli
Angiogenesis Inhibition
CYP2C9 protein, human
Celecoxib:MCnc:Pt:Ser/Plas:Qn
Expand
Broader (2)
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Narrower (3)
Celebrex
SC 58635
celecoxib-NBD
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects.
Y. Abassi
,
Biao Xi
,
+6 authors
Xiao Xu
Chemistry and Biology
2009
Corpus ID: 20991403
Highly Cited
2007
Highly Cited
2007
Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
Hector Guzmán
,
Mark D. Tawa
,
+7 authors
J. Remenar
Journal of Pharmacy and Science
2007
Corpus ID: 6557838
Biopharmaceutical evaluation of crystalline celecoxib salts in novel solid formulations, which were designed to simultaneously…
Expand
Highly Cited
2006
Highly Cited
2006
Indomethacin and Celecoxib Impair Rotator Cuff Tendon-to-Bone Healing
D. B. Cohen
,
S. Kawamura
,
J. Ehteshami
,
S. Rodeo
American Journal of Sports Medicine
2006
Corpus ID: 30052441
Background Nonsteroidal anti-inflammatory drugs are commonly prescribed after rotator cuff repair. These agents can impair bone…
Expand
Review
2005
Review
2005
Clinical Consequences of Cytochrome P450 2C9 Polymorphisms
J. Kirchheiner
,
J. Brockmöller
Clinical pharmacology and therapy
2005
Corpus ID: 45365027
Highly Cited
2004
Highly Cited
2004
Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Alexander Weber
,
A. Casini
,
+4 authors
G. Klebe
Journal of Medicinal Chemistry
2004
Corpus ID: 10134022
By optimizing binding to a selected target protein, modern drug research strives to develop safe and efficacious agents for the…
Expand
Highly Cited
2004
Highly Cited
2004
Celecoxib Induces Functional Recovery after Intracerebral Hemorrhage with Reduction of Brain Edema and Perihematomal Cell Death
K. Chu
,
Sang-Wuk Jeong
,
+4 authors
J. Roh
Journal of Cerebral Blood Flow and Metabolism
2004
Corpus ID: 20709986
The selective cyclooxygenase-2 (COX-2) inhibitor has been reported to have antiinflammatory, neuroprotective, and antioxidant…
Expand
Highly Cited
2004
Highly Cited
2004
Stability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective
P. Gupta
,
Vasu Kumar Kakumanu
,
A. Bansal
Pharmaceutical Research
2004
Corpus ID: 20695952
AbstractPurpose. The purpose of the current study is to evaluate the solubility advantage offered by celecoxib (CEL) amorphous…
Expand
Highly Cited
2004
Highly Cited
2004
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
M. Murias
,
N. Handler
,
+5 authors
W. Jäger
Bioorganic & Medicinal Chemistry
2004
Corpus ID: 37311373
Highly Cited
2000
Highly Cited
2000
Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.
S. Reuben
,
N. R. Connelly
Anesthesia and Analgesia
2000
Corpus ID: 40500191
UNLABELLED Nonsteroidal antiinflammatory drugs are recommended for the multimodal management of postoperative pain and may have a…
Expand
Highly Cited
1999
Highly Cited
1999
Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis
S. Fischer
,
Herng‐Hsang Lo
,
+4 authors
C. Conti
Molecular Carcinogenesis
1999
Corpus ID: 25382827
Epidemiological and dietary studies suggest that nonsteroidal anti‐inflammatory drugs (NSAIDs) reduce the risk of colon cancer…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE